Rx Drug Ads: New US FDA Studies Target Accelerated Approval Information
Upcoming research projects will look at presentation of FDA approval status, timing of disease awareness ads, and healthcare professional views.
You may also be interested in...
Study will assess responses of cancer survivors and caregivers to disclosures that a drug received accelerated approval. FDA analysis found that 73% of 26 accelerated approval drugs cited approval pathway on product websites.
US FDA plans to conduct a study to evaluate consumer comprehension of oncology indications in direct-to-consumer television advertising.
With only seven letters last year, Office of Prescription Drug Promotion appears to be continuing its enforcement retrenchment as agency reconsiders its approach to Rx communications.